Navigation Links
Telomerase enzyme structure provides significant new target for anti-cancer therapies
Date:11/13/2007

(PHILADELPHIA) Inappropriate activation of a single enzyme, telomerase, is associated with the uncontrollable proliferation of cells seen in as many as 90 percent of all of human cancers. Since the mid-1990s, when telomerase was first identified in human tumors, scientists have eyed the enzyme as an ideal target for developing broadly effective anti-cancer drugs.

Now, researchers working at The Wistar Institute have brought this goal closer by deciphering the three-dimensional structure of a domain, or region, of the telomerase molecule essential for the activity of the enzyme. The findings, published November 13 in the journal Structure, may help scientists develop strategies to design the first direct inhibitors of telomerase.

Telomerase also has been shown to play a central role in normal aging, and the new study may shed light on that vital life process as well. The potential for creating new cancer treatments, however, is the most important immediate implication of the study.

Knowing the physical structure of this complex will give pharmaceutical companies a direct target for designing drugs that disrupt a mechanism that telomerase uses to assemble itself, says Emmanuel Skordalakes, Ph.D., an assistant professor in the Gene Expression and Regulation Program at Wistar and senior author on the study. Such drugs could well have significant anti-cancer activity.

Telomerase is essential for normal cell division and survival, and has been associated with aging and cancer. In humans, the usual role of telomerase is to add multiple repeats of a short length of DNA to the ends of chromosomes, known as telomeres, thus preventing damage and the loss of genetic information during DNA replication. It performs this critical service in developing embryos and in a few specialized cell lines, including stem cells.

In normal adult cells, however, telomerase is switched off almost entirely to prevent the dangers of runaway cell
'/>"/>

Contact: Franklin Hoke
hoke@wistar.org
215-898-3716
The Wistar Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
3. Scientists reveal DNA-enzyme interaction with first ever real time footage
4. UCSD study reveals the regulatory mechanism of key enzyme
5. UCSD study reveals the regulatory mechanism of key enzyme
6. Enzymes second messenger contributes to cell overgrowth
7. Delaware Court Approves Bioenvision, Genzyme Joint Petition
8. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
9. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
10. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
11. Role of a key enzyme in reducing heart disease identified

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)..., , CHICAGO, Nov. 28 We...le PACS solution for the clinical routine from S...ing and Communications System (PACS) from Siemen...e place, syngo .plaza is poised to change the...is unveiling this innovation at the 95th Scienti...
(Date:11/28/2009)...Experts offer tips to help lift spirits, recognize...28 (HealthDay News) -- For many seniors, the holid...ut lost loved ones, struggle with health issues or...ican Geriatrics Society. , To help overcome the...Aging offers the following advice: , Get out and...
(Date:11/27/2009)..., , DALLAS, Nov. 27 /PRNewswire-USNewswire...edical procedure only 25 years ago, solid organ tr...ation thanks to the extraordinary men and women wh...n Nov. 11. Leaders came together from medical cent...sary of Baylor Regional Transplant Institute (BRTI...
(Date:11/27/2009)..., , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNews...asdaq: SHMR ) ( "Shamir" ), a leading provider of...mic lens market, announced today that its board of... an aggregate amount of US$ 10 million (approximat...09 representative rate of exchange), or approximat...
(Date:11/27/2009)..., , SEATTLE, Nov. 27 /PRNe... site, received record-high Thanksgiving traffic n...y before Thanksgiving, providing a clear picture o...he year. The average Thanksgiving meal in 2009 wei... increase from last year,s feast. According to the...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4
...esday the FDA issued a public health advisory, war... or other infection among women who have taken Dan...mifepristone -- which when taken with misoprostol ...nation of early pregnancy, defined as 49 or fewer ...
...pting red color of strawberries may be the culprit...en eating the popular summer fruit, Swedish resear...her related to the red color, but it is not clear ...cation of Britain's Royal Society of Chemistry. ...
... approved the first generic version of the AIDS dr...ured by Ranbaxy Laboratories. Due to patent laws i...drug in US, but it will be available for patients ...t’s emergency plan for AIDS relief was announced i...
...oss sectional study across Europe, researchers hav...n the education of the parents and their socio-eco...ce in children. The research that was carried acro...om poor families don’t necessarily have worse heal...
... Gengraine Technologies (Avesthagen) of India is c...d Industrialization fund for Developing Countries ...oint venture is estimated of 5 million euro. Avest...menopause linked to osteoporosis and development o...
...hers at the Institute of Food Technologists annual...ainst taking food borne illnesses casually and had...he health of the nation, if not taken enough preca.... A healthy adult is less likely to contract a foo...
Other Medicine News:Health News:Education And Income Level May Not Guarantee Health 2Health News:Scientists Warn Against Food Borne Illnesses 2
(Date:11/29/2009)...ire/ -- FUJIFILM Medical Systems USA, Inc., the wo...) with over 7,000 installations, is pleased to deb...n the US. The Aspire HD combines the use of advan...ration detector technology and the smallest pixel ...olution at a reduced dose for the patient. The fl...
(Date:11/28/2009)...re/ -- Siemens Healthcare redefines productivity ...aging matrix) technology and with its new Dot(TM) ...ies are introduced in the new MAGNETOM ® Aer...anners at the 95th Scientific Assembly and Annual ...ca (RSNA) from November 29 to December 3 at McCorm...
(Date:11/27/2009)...wire/ -- At the upcoming Radiological Society of N..., Royal Philips Electronics ( PHG, AEX: PHI) will ...informatics solutions designed to directly address... delivering meaningful imaging innovations that re... easy upgradability. This focus will enable Phili...
Breaking Medicine Technology:FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Wyeths Prevenar 13 Receives First Approval 51609 1Wyeths Prevenar 13 Receives First Approval 51609 2Wyeths Prevenar 13 Receives First Approval 51609 3Wyeths Prevenar 13 Receives First Approval 51609 4Wyeths Prevenar 13 Receives First Approval 51609 5Julie Stav Reminds Hispanic Moms to Invest in Their Familys Wellness with Milk 21 51606 1Julie Stav Reminds Hispanic Moms to Invest in Their Familys Wellness with Milk 21 51606 2Julie Stav Reminds Hispanic Moms to Invest in Their Familys Wellness with Milk 21 51606 3Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 1Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 2Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 3
...wide, MENLO PARK, Calif., Nov. 15 Cogentus Pharm...global Phase III clinical program to,evaluate the ...py CGT-2168.,The program, which includes the COGEN...tients at hundreds of sites in the United States, ...ww.newscom.com/cgi-bin/prnh/20071112/COGENTUSLOGO ...
... 15 BiPar,Sciences, Inc., a privately held biopha...ies, today announced it has initiated a Phase 2 st...ts with triple-negative breast,cancer that do not ...rs. The company designed the Phase 2 trial in thi...l need-based on molecular biomarker data,presented...
Other Medicine Technology:Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 3
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: